About

About KIOMED PHARMA Capitalizing on a history of innovation and expertise in exclusive natural chitosan chemistry, KiOmed Pharma, a commercial-stage biotech spinout from KitoZyme, develops a unique pipeline of medical devices that address unmet medical needs in high-impact pathologies and major social burdens such as invalidating OsteoArthritis, Skin Aging and Ophthalmology. KiOmed Pharma's innovative pipeline is based on a solid building block exclusive technology: KiOmedine®, a medical-grade highly pure natural chitosan-derivative. About KIOMED PHARMA Capitalizing on a history of innovation and expertise in exclusive natural chitosan chemistry, KiOmed Pharma, a commercial-stage biotech spinout from KitoZyme, develops a unique pipeline of medical devices that address unmet medical needs in high-impact pathologies and major social burdens such as invalidating OsteoArthritis, Skin Aging and Ophthalmology. KiOmed Pharma's innovative pipeline is based on a solid building block exclusive technology: KiOmedine®, a medical-grade highly pure natural chitosan-derivative. Capitalizing on a history of innovation and expertise in exclusive natural chitosan chemistry, KiOmed Pharma, a commercial-stage biotech spinout from KitoZyme and the University of Liege, has developpeds a unique pipeline of medical devices that address unmet medical needs in high-impact pathologies and major social burdens such as invalidating OsteoArthritis, Skin Aging and Ophthalmology. KiOmed Pharma's innovative pipeline is based on a solid building block exclusive technology: KiOmedine®, a medical-grade highly pure natural chitosan-derivative. KioMedine-vs-one, the company’s first product, currently commercialized in 15 countries, is a unique fluid implant indicated for the symptomatic treatment of knee osteoarthritis via a single intraarticular injection, providing up to 12 months symptom relief. KioMedine-vs-one is targeted to refractory knee OA patients, who do not respond well to existing treatments and constitutes for these patients a cost-effective alternative to TKR surgery, that can potentially be delayed or avoided.